EUVIMEDOpdag EUVIMED
Open access

Prevalence Patterns of Children's Interstitial and Diffuse Lung Disease (chILD) in Colombia, 2016–2024

Andrea Parra Buitrago iD, Jefferson Antonio Buendía iD

Pediatric Pulmonology · 2026

DOI: 10.1002/ppul.71832 ↗

At a glance

Journal article in Pediatric Pulmonology, 2026. Written by Andrea Parra Buitrago and 1 co-authors. Institution: Departamento de Neumología Pediátrica, Hospital Pablo Tobón Uribe, Facultad de Medicina, Universidad Pontificia Bolivariana, Medellín, Colombia. Major MEDLINE topics: Lung Diseases, Interstitial. 37 references. The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Children's interstitial and diffuse lung disease (chILD) comprise a heterogeneous group of rare disorders associated with substantial morbidity and mortality. Population‐based epidemiological data remain scarce in low‐ and middle‐income countries, limiting health system planning and policy development. We aimed to estimate the prevalence and temporal trends of chILD in Colombia using nationwide administrative healthcare data.

Methods

We conducted a retrospective, population‐based study using Colombia's Registro Individual de Prestación de Servicios de Salud (RIPS) from 2016 to 2024. chILD cases were identified using ICD‐10 codes for chILD in individuals aged 0–18 years. Prevalence was estimated overall, by year, sex, age group, and diagnosis. Crude and WHO age‐standardized prevalence rates were calculated per 100,000 population. Temporal trends were assessed using Poisson regression and LOESS smoothing.

Results

A total of 4608 chILD ‐related healthcare encounters were identified. The average annual crude prevalence was 3.32 per 100,000 children (age‐standardized: 3.39 per 100,000). Prevalence was highest in infants younger than 1 year and showed a secondary increase during adolescence. No relevant sex differences were observed. A significant annual increase in reported cases was detected (IRR 1.022; 95% CI 1.011–1.034), with a marked decline during the COVID‐19 pandemic. Alveolar and fibrotic interstitial lung disease categories accounted for most cases.

Conclusions

This first nationwide study provides robust real‐world evidence on the epidemiology of chILD in Colombia, revealing substantial healthcare utilization and distinct age‐related patterns. Administrative data represents a valuable complementary tool for surveillance of rare pediatric lung diseases.

Subjects

MeSH terms (MEDLINE)

Lung Diseases, InterstitialHumansColombiaChild, PreschoolMaleFemalePrevalenceInfantChildRetrospective StudiesAdolescentInfant, NewbornAge Distribution

Authors and institutions

  • Departamento de Neumología Pediátrica, Hospital Pablo Tobón Uribe, Facultad de Medicina, Universidad Pontificia Bolivariana, Medellín, Colombia.
  • Departamento de Farmacología y Toxicología, Facultad de Medicina, Grupo de Investigación en Farmacología y Toxicología, Universidad de Antioquia, Medellín, Colombia.

ORCID profiles: Andrea Parra Buitrago, Jefferson Antonio Buendía

Cite

APA

Buitrago, A. P., & Buendía, J. A. (2026). Prevalence Patterns of Children's Interstitial and Diffuse Lung Disease (chILD) in Colombia, 2016–2024. Pediatric Pulmonology. https://doi.org/10.1002/ppul.71832

Vancouver

Buitrago AP, Buendía JA. Prevalence Patterns of Children's Interstitial and Diffuse Lung Disease (chILD) in Colombia, 2016–2024. Pediatric Pulmonology. 2026. doi:10.1002/ppul.71832

BibTeX
@article{Buitrago2026,
  author = {Buitrago, Andrea Parra and Buendía, Jefferson Antonio},
  title = {Prevalence Patterns of Children's Interstitial and Diffuse Lung Disease (chILD) in Colombia, 2016–2024},
  journal = {Pediatric Pulmonology},
  year = {2026},
  doi = {10.1002/ppul.71832}
}
Start for free →